040-000-322 Atenolol, CAS 29122-68-7

SKU: 040-000-322 Category:
Get A Quote






  I would like to join the mailing list to receive updates from Stanford Chemicals.
*: e-mail address with your company's domain name is preferred. Otherwise, we may not be able to process your inquiry.

Synonyms Altol;1-p-carbamoylmethylphenoxy-3-isopropylamino-2-propanol;atenol;4-(2-hydroxy-3-[(1-methylethyl)amino]propoxy)benzeneacetamide; tenormine
Keywords Hypertension, glaucoma, angina, Selective β1 adrenoceptor antagonists
Related products Timclol Maleate, Losartan Potassium, Horny Goat Weed Extract
Description

Description

Atenolol Specifications

Product Name Atenolol
CAS Registry Number 29122-68-7
Molecular Formula C14H22N2O3
Molecular Weight 266.163 g/mol
Appearance White powder
Package 1kg-25kg
Shelf life 2 years
Functions Mainly used for the treatment of hypertension, angina, myocardial infarction, but also for arrhythmia, hyperthyroidism, pheochromocytoma

Atenolol Description

The molecular formula of atenolol is C14H22N2O3. In 1976, atenolol was developed to replace propranolol as a treatment for hypertension, which can reduce the activity of the heart. But unlike propranolol, atenolol does not cross the blood-brain barrier, thereby avoiding various side effects on the central nervous system.

Atenolol is used with or without other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication is also used to treat chest pain (angina) and to improve survival after a heart attack. Atenolol belongs to a class of drugs known as beta blockers.

atenolol

Atenolol Applications

  • As a pharmaceutical ingredient mainly used for the treatment of hypertension, angina, and myocardial infarction, but also for arrhythmia, hyperthyroidism, and pheochromocytoma.

Reference:

  1. Viveksarathi et al., Formulation Development and In-Vitro Evaluation of Gastroretentive Floating tablets of Atenolol. Journal of Pharmaceutical Sciences & Research;2011, Vol.3(12),p1632.